CD58 acts as a tumor promotor in hepatocellular carcinoma via activating the AKT/GSK-3β/β-catenin pathway

Table 2 Cox regression analysis of prognosis in 69 HCC patients

Factors	SE	p value	HR	95%CI
Factors	SE	p value	HR	Lower	Upper
CD58 expression
High (n = 55) versus low (n = 14)	0.773	0.044*	4.762	1.046	21.668
Age
< 60 versus ≥ 60	0.015	0.224	1.018	0.989	1.048
Sex
Male versus female	0.480	0.240	1.759	0.686	4.509
Tumor size
≤ 5 cm versus > 5 cm	0.384	0.177	1.679	0.791	3.565
Differentiation level
Low/Middle versus high	0.522	0.915	0.946	0.340	2.631
AFP (μg /L)
< 60 versus ≥ 60	0.483	0.673	0.831	0.352	1.962
Satellite focus
With versus without	0.366	0.014*	2.466	1.203	5.053
Tumor thrombus
With versus without	0.391	0.146	1.767	0.821	3.807
Liver cirrhosis
With versus without	0.369	0.995	0.882	0.428	1.816

ISSN: 1479-5876